| Bioactivity | MRS2298? is a potent acyclic P2Y1 receptor antagonist with a Ki of 29.6 nM. MRS2298 inhibits the ADP-induced aggregation of human platelets with an IC50 of 62.8 nM. MRS2298 inhibits Ca2+ rise in platelets with an IC50 of 810 nM[1]. |
| Name | MRS2298 |
| CAS | 491611-43-9 |
| Formula | C10H16ClN5O8P2 |
| Molar Mass | 431.66 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Marco Cattaneo, et al. Antiaggregatory activity in human platelets of potent antagonists of the P2Y 1 receptor. Biochem Pharmacol. 2004 Nov 15;68(10):1995-2002. |
MRS2298
CAS: 491611-43-9 F: C10H16ClN5O8P2 W: 431.66
MRS2298? is a potent acyclic P2Y1 receptor antagonist with a Ki of 29.6 nM. MRS2298 inhibits the ADP-induced aggregation
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.